Evidence map›Paper›PMID 40413873›Full record

ReviewHealth policy (Amsterdam, Netherlands)2025

The second Trump administration: A policy analysis of challenges and opportunities for European health policymakers.

Scott L Greer, Holly Jarman, Rachel Kulikoff, Dimitra Panteli, Ewout van Ginneken, Matthias Wismar

Abstract readReview
In one paragraph

Review in Health policy (Amsterdam, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Scott L GreerHealth Management and Policy, Global Public Health and Political Science, University of Michigan School of Public Health, Senior Expert Advisor on Health Governance, European Observatory on Health Systems and Policies, Ann Arbor, MI, 48019-2029, USA. Electronic address: slgreer@umich.edu.
Holly JarmanHealth Management and Policy, University of Michigan School of Public Health, Ann Arbor, MI, 48019-2029, USA.
Rachel KulikoffHealth Management and Policy, University of Michigan School of Public Health, Ann Arbor, MI, 48019-2029, USA.
Dimitra PanteliHub Coordinator- Berlin, European Observatory on Health Systems and Policies, Eurostation (Office 07C020), Place Victor Horta/Victor Hortaplein, 40 bte 30, 1060, Brussels, Belgium.
Ewout van GinnekenEuropean Observatory on Health Systems and Policies, Eurostation (Office 07C020), Place Victor Horta/Victor Hortaplein, 40 bte 30, 1060, Brussels, Belgium.
Matthias WismarEuropean Observatory on Health Systems and Policies, Eurostation (Office 07C020), Place Victor Horta/Victor Hortaplein, 40 bte 30, 1060, Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe second Trump administration has already made major changes in US policies that affect health and health systems worldwide.

methodsWe use the Health System Performance Assessment categories developed by the European Observatory on Health Systems and Policies to identify areas in which US actions affect the health systems and policies of European states and the EU, and presidential Executive Orders supplemented by campaign statements to understand US actions.

resultsWe identify relevant US policies in the areas of finance, resource generation (regulation, vaccines, artificial intelligence, supply chain resilience, workforce, research, education) and governance (geopolitical turbulence, climate change, US departure from the World Health Organization, and foreign aid). We then identify opportunities for states or the EU to strengthen their health systems, potential threats to their health systems that might arise from US actions, and serious confirmed threats.

conclusionThe second Trump administration is creating heavy demands on European governments in many areas, which might undermine their fiscal capacity and willingness to fund health systems or new ventures, but diminished US investment in areas such as multilateralism, pandemic response, research, education, and aid (especially in areas such as gender and reproductive health) all create opportunities for European policymakers to strengthen their health systems, health-related economic sectors, and influence in global health governance.

Indexed as

Delivery of Health CareHealth PolicyPolicy MakingPoliticsEuropeHumansUnited StatesClimate changeDonald trumpGlobal health governanceHealth financingHealth workforcePharmaceuticalsResearchUnited StatesVaccines

Identifiers

PMID40413873
PMCPMC12178252

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.